Nasus Pharma Ltd.

Nasus Pharma Ltd.

NSRX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$29.89M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nasus Pharma Ltd.Nasus Pharma Ltd.-2.8--99%--
$0.14

Current Fair Value

94.8% downside

Overvalued by 94.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$29.89 Million
Enterprise Value$22.18 Million
Earnings per Share$-0.72
Beta4.26
Outstanding Shares11,070,458

Return

Return on Equity-99.41%ROE
Return on Assets-87.81%
Return on Invested Capital-96.09%

Valuation & Multiples

P/E Ratio-2.8P/E Ratio
PEG-0.33PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-2.09
Enterprise Value to Net Income-3
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 17, 2026
EPS
-$0.54
Est. -$0.27
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
-$0.67
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nasus Pharma Ltd.

7 employees
CEO: Brendan O'Grady

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditio...

Nasus Pharma Insider Information FAQ

Stockcircle shows 1 open-market insider purchase for Nasus Pharma in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.